Bank of America’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.69M Buy
1,595,219
+1,186,042
+290% +$6.65M ﹤0.01% 3076
2025
Q4
$2.86M Sell
409,177
-252,425
-38% -$1.98M ﹤0.01% 3788
2025
Q3
$5.11M Sell
661,602
-683,443
-51% -$5.33M ﹤0.01% 3987
2025
Q2
$11.7M Sell
1,345,045
-674,419
-33% -$4.89M ﹤0.01% 3094
2025
Q1
$16.1M Buy
2,019,464
+1,375,308
+214% +$13.9M ﹤0.01% 2686
2024
Q4
$5.86M Sell
644,156
-642,585
-50% -$6.2M ﹤0.01% 3438
2024
Q3
$11.8M Buy
1,286,741
+489,287
+61% +$4.05M ﹤0.01% 2912
2024
Q2
$7.8M Sell
797,454
-329,795
-29% -$4.02M ﹤0.01% 3195
2024
Q1
$17M Buy
1,127,249
+448,268
+66% +$8.13M ﹤0.01% 2446
2023
Q4
$14.6M Sell
678,981
-221,335
-25% -$4.08M ﹤0.01% 2455
2023
Q3
$16.7M Buy
900,316
+54,014
+6% +$1.26M ﹤0.01% 2222
2023
Q2
$21.4M Sell
846,302
-293,093
-26% -$7.38M ﹤0.01% 1970
2023
Q1
$29.5M Buy
1,139,395
+290,339
+34% +$7.77M ﹤0.01% 1777
2022
Q4
$20.1M Buy
849,056
+49,074
+6% +$1.32M ﹤0.01% 2025
2022
Q3
$20.3M Sell
799,982
-261,632
-25% -$9.18M ﹤0.01% 1944
2022
Q2
$35.3M Sell
1,061,614
-906,066
-46% -$38.5M ﹤0.01% 1506
2022
Q1
$142M Sell
1,967,680
-59,678
-3% -$4.3M 0.01% 786
2021
Q4
$186M Buy
2,027,358
+187,906
+10% +$22.5M 0.02% 698
2021
Q3
$233M Sell
1,839,452
-29,988
-2% -$4.37M 0.02% 574
2021
Q2
$311M Sell
1,869,440
-673,257
-26% -$109M 0.03% 475
2021
Q1
$462M Buy
2,542,697
+326,284
+15% +$75.7M 0.05% 335
2020
Q4
$443M Sell
2,216,413
-82,208
-4% -$16.7M 0.06% 303
2020
Q3
$504M Sell
2,298,621
-242,286
-10% -$51.3M 0.07% 253
2020
Q2
$485M Buy
2,540,907
+180,030
+8% +$31.5M 0.07% 249
2020
Q1
$366M Sell
2,360,877
-190,775
-7% -$22.2M 0.07% 265
2019
Q4
$214M Sell
2,551,652
-628,444
-20% -$47.8M 0.03% 477
2019
Q3
$215M Buy
3,180,096
+907,972
+40% +$59.8M 0.03% 456
2019
Q2
$151M Sell
2,272,124
-16,406
-0.7% -$956K 0.02% 585
2019
Q1
$127M Buy
2,288,530
+250,054
+12% +$15.3M 0.02% 641
2018
Q4
$101M Buy
2,038,476
+61,013
+3% +$3.73M 0.02% 674
2018
Q3
$171M Buy
1,977,463
+94,278
+5% +$6.72M 0.03% 529
2018
Q2
$109M Buy
1,883,185
+853,076
+83% +$41.7M 0.02% 663
2018
Q1
$41.5M Buy
1,030,109
+59,190
+6% +$2.23M 0.01% 1182
2017
Q4
$33.8M Buy
970,919
+555,807
+134% +$18.5M 0.01% 1386
2017
Q3
$13.8M Buy
415,112
+170,732
+70% +$5.6M ﹤0.01% 2196
2017
Q2
$8.48M Buy
244,380
+30,463
+14% +$888K ﹤0.01% 2538
2017
Q1
$5.35M Buy
213,917
+198,936
+1,328% +$4.14M ﹤0.01% 2953
2016
Q4
$247K Buy
14,981
+5,425
+57% +$92.1K ﹤0.01% 5221
2016
Q3
$175K Buy
9,556
+2,550
+36% +$44.7K ﹤0.01% 5189
2016
Q2
$113K Buy
7,006
+561
+9% +$6.54K ﹤0.01% 5461
2016
Q1
$62K Sell
6,445
-1,666
-21% -$23.7K ﹤0.01% 5695
2015
Q4
$146K Sell
8,111
-1,754
-18% -$32.4K ﹤0.01% 5557
2015
Q3
$221K Buy
+9,865
New +$266K ﹤0.01% 5281

Other funds holding TDOC

Bank of America's TDOC Position: Q1 2026 in Review

Bank of America increased its Teladoc Health (TDOC) stake by 290% in Q1 2026, buying an estimated $6.65M and bringing the position to 1,595,219 shares worth $8.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3076.

Bank of America first reported a position in TDOC in Q3 2015 and has held it in 43 quarters since. The position peaked at $504M in Q3 2020. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Bank of America held 1,595,219 shares of Teladoc Health worth $8.69M as of Q1 2026.
  • Bank of America bought 1,186,042 Teladoc Health shares in Q1 2026, an estimated $6.65M.
  • Teladoc Health made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3076 holding.
  • Bank of America first reported a position in Teladoc Health in Q3 2015 and has held it in 43 quarters since.
  • Bank of America's Teladoc Health position peaked at $504M in Q3 2020.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.